The Association Between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Clinical Presentation of Coronary Artery Disease in Patients Underwent Percutaneous Coronary Interventio
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000023461
- Lead Sponsor
- ishiarai Heart Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who already received EPA supplementation at the time of PCI.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of coronary artery disease and EPA/AA ratio
- Secondary Outcome Measures
Name Time Method